Pharmaceutical Press Releaseshttp://www.pharmiweb.com/Press Releases in the Pharmaceutical Industry. News, Jobs and Resources at PharmiWeb.comen-gb&#169; 1998 - 2012 PharmiWeb Solutions - All Rights ReservedFri, 17 May 2012 01:00:00 GMTPharmiWeb.comhttp://www.pharmiweb.com/images/logos/pweb_logo.gifhttp://www.Pharmiweb.com20http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58736Psychiatric Times covers American Psychiatric Association Convention<strong>Psychiatric Times covers American Psychiatric Association Convention</strong><br />PR NewswireNORWALK, Conn., May 16, 2012NORWALK, Conn., May ...<br />UBM MEDICAhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58736Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58735Full Breadth and Depth of Accuray's Advanced, Personalized Radiation Treatment Capabilities Showcased at Estro 31<strong>Full Breadth and Depth of Accuray&apos;s Advanced, Personalized Radiation Treatment Capabilities Showcased at Estro 31</strong><br />PR Newswi...<br />Accurayhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58735Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58734BioAmber is Revolutionizing Renewable Chemistry<strong>BioAmber is Revolutionizing Renewable Chemistry</strong><br /> Industry excellence is being celebrated as BioAmber moves steadily toward cons...<br />BIOTECanadahttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58734Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58733Scientia Advisors’ Patrick Terry to be featured speaker at the Genome-wide Partnering and Deal-making Conference<strong>Scientia Advisors’ Patrick Terry to be featured speaker at the Genome-wide Partnering and Deal-making Conference</strong><br /> Scientia Advis...<br />Scientia Advisorshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58733Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58732Aggredyne Receives CE Mark for AggreGuideTM A-100<strong>Aggredyne Receives CE Mark for AggreGuideTM A-100</strong><br /> Aggredyne, Inc. (www.aggredyne.com), a Houston-based biomedical diagnostics ...<br />Aggredyne Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58732Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58731STENTYS Self-Apposing® Stent shows very low mortality at one month in 1,000 high-risk heart attack patients<strong>STENTYS Self-Apposing® Stent shows very low mortality at one month in 1,000 high-risk heart attack patients</strong><br />STENTYS S.A. (STNT.P...<br />STENTYS S.A.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58731Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58730CTG to Present on May 23, 2012 at the B. Riley & Co. 13th Annual Investor Conference<strong>CTG to Present on May 23, 2012 at the B. Riley &amp; Co. 13th Annual Investor Conference</strong><br />PR NewswireBUFFALO, N.Y., May 16, 2012...<br />CTGhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58730Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58729Cloud-Based Medical Billing Software Company Kareo Brings Enterprise-Grade Claim Scrubbing Technology to Small Medical Practices<strong>Cloud-Based Medical Billing Software Company Kareo Brings Enterprise-Grade Claim Scrubbing Technology to Small Medical Practices</strong><br /...<br />SS PUBLIC RELATIONS INChttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58729Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58728Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical Officer<strong>Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical Officer</strong><br />Epizyme, Inc., a company leading the discovery an...<br />Epizyme Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58728Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58727Research and Markets: Bronchiolitis - Pipeline Review, H1 2012<strong>Research and Markets: Bronchiolitis - Pipeline Review, H1 2012</strong><br />Research and Markets (http://www.researchandmarkets.com/research/...<br />Research and Marketshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58727Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58726FINRA Warns Investors of Nutraceutical Stock Scams<strong>FINRA Warns Investors of Nutraceutical Stock Scams</strong><br /> The Financial Industry Regulatory Authority (FINRA) issued a new Investor A...<br />Financial Industry Regulatory Authority (FINRA)http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58726Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58725Research and Markets: Helicobacter Pylori Infections - Pipeline Review, H1 2012<strong>Research and Markets: Helicobacter Pylori Infections - Pipeline Review, H1 2012</strong><br />Research and Markets (http://www.researchandmark...<br />Research and Marketshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58725Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58724Michael Jacobs, R.Ph., Joins Truveris Inc., Bringing Years of Pharmacy Expertise to PBM Claims Data and RFP Management Company<strong>Michael Jacobs, R.Ph., Joins Truveris Inc., Bringing Years of Pharmacy Expertise to PBM Claims Data and RFP Management Company</strong><br /> ...<br />Truverishttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58724Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58723Research and Markets: Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments<strong>Research and Markets: Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclero...<br />Research and Marketshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58723Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58722Herbalife Ltd. to Present at the Janney Consumer Conference<strong>Herbalife Ltd. to Present at the Janney Consumer Conference</strong><br /> Herbalife Ltd. (NYSE: HLF) Chief Financial Officer John DeSimone, a...<br />Herbalife Ltd.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58722Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58721Research and Markets: Wounds - Pipeline Review, H1 2012<strong>Research and Markets: Wounds - Pipeline Review, H1 2012</strong><br />Research and Markets (http://www.researchandmarkets.com/research/zvmjf5/...<br />Research and Marketshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58721Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58720Research and Markets: Scar - Pipeline Review, H1 2012<strong>Research and Markets: Scar - Pipeline Review, H1 2012</strong><br />Research and Markets (http://www.researchandmarkets.com/research/bqs2pd/sc...<br />Research and Marketshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58720Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58719The French Competitiveness Health Cluster EUROBIOMED is proud to announce that a delegation of SMEs members will attend the ‘Israel Biomed 2012’ on 21st-23rd May 2012, in Tel-Aviv<strong>The French Competitiveness Health Cluster EUROBIOMED is proud to announce that a delegation of SMEs members will attend the ‘Israel Biomed 201...<br />Eurobiomedhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58719Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58718Research and Markets: Regulation of Pharmaceutical Manufacturers - A Valuable Guide for Pharmaceutical Lawyers<strong>Research and Markets: Regulation of Pharmaceutical Manufacturers - A Valuable Guide for Pharmaceutical Lawyers</strong><br />Research and Mark...<br />Research and Marketshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58718Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58717Viropro, Inc. to Unlock Value from its Biosimilars Portfolio<strong>Viropro, Inc. to Unlock Value from its Biosimilars Portfolio</strong><br />VIROPRO (VPRO.PK).Viropro creates a biosimilars technology subsidi...<br />Viropro Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58717Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58716Even as UCB’s Keppra Captures the Largest Patient Share, Followed by GSK’s Lamictal, Strong Company Support and Positive Efficacy Performance Drive Uptake of UCB’s Vimpat in the Epilepsy Market, According to a Recent BioTrends Report<strong>Even as UCB’s Keppra Captures the Largest Patient Share, Followed by GSK’s Lamictal, Strong Company Support and Positive Efficacy Performance ...<br />BioTrends Research Grouphttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58716Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58715DiscoveRx Introduces a High-Throughput Biochemical Screening Platform for Bromodomain Epigenetic “Reader” Proteins<strong>DiscoveRx Introduces a High-Throughput Biochemical Screening Platform for Bromodomain Epigenetic “Reader” Proteins</strong><br /> DiscoveRx Co...<br />DiscoveRx Corporationhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58715Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58714Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A<strong>Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A</strong><br /> Baxter International Inc. (NYSE:BAX) today announce...<br />Baxter International Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58714Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58713Cubist Pharmaceuticals Marks 20th Anniversary by Making Its Largest-Ever Commitment to STEM Programs<strong>Cubist Pharmaceuticals Marks 20th Anniversary by Making Its Largest-Ever Commitment to STEM Programs</strong><br />Cubist Pharmaceuticals, In...<br />Cubist Pharmaceuticals Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58713Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58712Oramed Pharmaceuticals Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins<strong>Oramed Pharmaceuticals Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins</strong><br /> Marking a major milestone fo...<br />Oramed Pharmaceuticals Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58712Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58711Ra Pharmaceuticals Unveils Hereditary Angioedema as Lead Program Leveraging Its Cyclomimetic Discovery Platform<strong>Ra Pharmaceuticals Unveils Hereditary Angioedema as Lead Program Leveraging Its Cyclomimetic Discovery Platform</strong><br /> Ra Pharmaceutic...<br />Ra Pharmaceuticalshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58711Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58710Fibrocell Science, Inc. Announces Exclusive License Agreement with UCLA on Dermal Cell Research to Advance the Development of Personalized Cell Therapies<strong>Fibrocell Science, Inc. Announces Exclusive License Agreement with UCLA on Dermal Cell Research to Advance the Development of Personalized Cel...<br />Fibrocell Science Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58710Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58709Verdezyne Names Ray W. Miller as Chief Business Officer<strong>Verdezyne Names Ray W. Miller as Chief Business Officer</strong><br /> Verdezyne, Inc., a privately-held industrial biotechnology company foc...<br />Verdezyne Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58709Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58708Biovest Retains Ferghana Partners to Evaluate Strategic Transactions<strong>Biovest Retains Ferghana Partners to Evaluate Strategic Transactions</strong><br /> Biovest International, Inc. (OTCQB:BVTI), a majority-owned...<br />Biovest International Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58708Thu, 16 May 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58707CORRECTING and REPLACING Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries<strong>CORRECTING and REPLACING Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed ...<br />Medtronic Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=58707Thu, 16 May 2012 01:00:00 GMT